Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)

ABSTRACT: General Objectives: * To test the feasibility of neoadjuvant treatment with cetuximab/chemotherapy followed by liver resection * To determine the optimal combination (cetuximab/FOLFOX versus cetuximab/FOLFIRI) for further trials in preoperative chemotherapy

DISEASE(S): Neoplasm Metastasis,Liver Metastases,Colorectal Cancer,Liver Neoplasms

PROVIDER: 2016055 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR